Skip to main content
Top
Published in: Endocrine Pathology 4/2015

01-12-2015

Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis

Authors: Lori A. Erickson, Julie A. Vrana, Jason Theis, Michael Rivera, Ricardo V. Lloyd, Ellen McPhail, Jun Zhang

Published in: Endocrine Pathology | Issue 4/2015

Login to get access

Abstract

Amyloid is a characteristic histologic feature in medullary thyroid carcinomas (MTC). We utilized a novel mass spectrometry-based proteomic analysis to determine if we could identify specific proteins associated with amyloid in MTC. We studied 9 MTC (1 multiple endocrine neoplasia type 2A, 1 familial MTC, and 7 sporadic). Laser microdissection was utilized to sample the amyloid which was then trypsin digested and evaluated by liquid chromatography electrospray tandem MS (LC-MS/MS) which identified the presence of amyloidogenic proteins in all cases of MTC. High levels of calcitonin were identified in all 9 cases of MTC. Secretogranin-1 was identified in 6 of 9 MTC. Calcitonin gene-related peptide was identified in 4 of 9 cases of MTC. LC-MS/MS proteomic analysis provides a rapid, highly specific, and sensitive method for identification of the specific type of amyloid in these endocrine tumors. This approach may allow classification of different forms of endocrine amyloid present in neuroendocrine tumors.
Literature
1.
go back to reference Vrana JA, Gamez JD, Madden BJ et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114(24):4957–4959, 2009.CrossRefPubMed Vrana JA, Gamez JD, Madden BJ et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114(24):4957–4959, 2009.CrossRefPubMed
2.
go back to reference Dasari S, Theis JD, Vrana JA et al. Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses. J Proteome Res. 13(5):2352–23588, 2014CrossRefPubMed Dasari S, Theis JD, Vrana JA et al. Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses. J Proteome Res. 13(5):2352–23588, 2014CrossRefPubMed
3.
go back to reference Vrana JA, Theis JD, Dasari S, et al. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 99(7):1239–1247, 2014.PubMedCentralCrossRefPubMed Vrana JA, Theis JD, Dasari S, et al. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 99(7):1239–1247, 2014.PubMedCentralCrossRefPubMed
4.
go back to reference Sethi S, Vrana JA, Theis JD, Dogan A. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens. 22(3):273–80, 2013.CrossRefPubMed Sethi S, Vrana JA, Theis JD, Dogan A. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens. 22(3):273–80, 2013.CrossRefPubMed
5.
go back to reference Maleszewski JJ, Murray DL, Dispenzieri A, et al. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 22(3):189–194, 2013.CrossRefPubMed Maleszewski JJ, Murray DL, Dispenzieri A, et al. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 22(3):189–194, 2013.CrossRefPubMed
6.
go back to reference Albores-Saavedra J, Rose GG, Ibanez ML et al. The amyloid in solid carcinoma of the thyroid gland: staining characteristics, tissue cultures and electron microscopic observations. Lab Invest 13:77–89, 1964.PubMed Albores-Saavedra J, Rose GG, Ibanez ML et al. The amyloid in solid carcinoma of the thyroid gland: staining characteristics, tissue cultures and electron microscopic observations. Lab Invest 13:77–89, 1964.PubMed
7.
go back to reference Meyer JS. Fine structure of two amyloid-forming medullary carcinomas of thyroid. Cancer 21(3):406–425, 1968.CrossRefPubMed Meyer JS. Fine structure of two amyloid-forming medullary carcinomas of thyroid. Cancer 21(3):406–425, 1968.CrossRefPubMed
8.
go back to reference Meyer JS, Hutton WE, Kenny AD. Medullary carcinoma of thyroid gland. Subcellular distribution of calcitonin and relationship between granules and amyloid. Cancer 31(2):433–41, 1973CrossRefPubMed Meyer JS, Hutton WE, Kenny AD. Medullary carcinoma of thyroid gland. Subcellular distribution of calcitonin and relationship between granules and amyloid. Cancer 31(2):433–41, 1973CrossRefPubMed
9.
go back to reference Arnal-Monreal FM, Goltzman D, Knaack J, Wang NS, Huang SN. Immunohistologic study of thyroidal medullary carcinoma and pancreatic insulinoma. Cancer 40(3):1060–1070, 1977.CrossRefPubMed Arnal-Monreal FM, Goltzman D, Knaack J, Wang NS, Huang SN. Immunohistologic study of thyroidal medullary carcinoma and pancreatic insulinoma. Cancer 40(3):1060–1070, 1977.CrossRefPubMed
10.
go back to reference Sletten K, Westermark P, Natvig JB. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143(4):993–998, 1976.CrossRefPubMed Sletten K, Westermark P, Natvig JB. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143(4):993–998, 1976.CrossRefPubMed
11.
go back to reference Khurana R, Agarwal A, Bajpai VK, et al. Unraveling the amyloid associated with human medullary thyroid carcinoma. Endocrinology 145(12):5465–5470, 2004.CrossRefPubMed Khurana R, Agarwal A, Bajpai VK, et al. Unraveling the amyloid associated with human medullary thyroid carcinoma. Endocrinology 145(12):5465–5470, 2004.CrossRefPubMed
12.
go back to reference Sipe JD, Benson MD, Buxbaum JN, Ikeda, S, Merlini G, Saraiva MJM, Westermark P. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21(4):221–224, 2014.CrossRefPubMed Sipe JD, Benson MD, Buxbaum JN, Ikeda, S, Merlini G, Saraiva MJM, Westermark P. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21(4):221–224, 2014.CrossRefPubMed
13.
go back to reference Knowles TPJ, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15:384–396, 2014.CrossRefPubMed Knowles TPJ, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15:384–396, 2014.CrossRefPubMed
14.
go back to reference Chiti F and Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Bioch 75:333–366, 2006.CrossRef Chiti F and Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Bioch 75:333–366, 2006.CrossRef
15.
go back to reference Benedum UM, Lamouroux A, Konecki DS, et al. The Primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO J 6(5): 1203–1211, 1987.PubMedCentralPubMed Benedum UM, Lamouroux A, Konecki DS, et al. The Primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO J 6(5): 1203–1211, 1987.PubMedCentralPubMed
16.
go back to reference Durham P and Russo A. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 23(3):807–815, 2003PubMed Durham P and Russo A. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 23(3):807–815, 2003PubMed
17.
go back to reference Schafers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23(7):2517–2521, 2003.PubMed Schafers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23(7):2517–2521, 2003.PubMed
18.
go back to reference Arulmani U, VanDenBrink AM, Villalon CM, Saxena PR. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 500(1–3):315–330, 2004.CrossRefPubMed Arulmani U, VanDenBrink AM, Villalon CM, Saxena PR. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 500(1–3):315–330, 2004.CrossRefPubMed
19.
go back to reference Russell FA, King R, Smillie SJ, et al. Calcitonin gene-related peptide: physiology and pathophysiology. Brain Physiological Reviews 94(4):1099–1142, 2014.CrossRefPubMed Russell FA, King R, Smillie SJ, et al. Calcitonin gene-related peptide: physiology and pathophysiology. Brain Physiological Reviews 94(4):1099–1142, 2014.CrossRefPubMed
Metadata
Title
Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis
Authors
Lori A. Erickson
Julie A. Vrana
Jason Theis
Michael Rivera
Ricardo V. Lloyd
Ellen McPhail
Jun Zhang
Publication date
01-12-2015
Publisher
Springer US
Published in
Endocrine Pathology / Issue 4/2015
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-015-9390-7

Other articles of this Issue 4/2015

Endocrine Pathology 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.